Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 8/20 | 0.40 |
| ▸ | CTSS | P25774 | 2/20 | 0.35 |
| ▸ | CTSK | P43235 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.32 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18179190 | 0.89 | AAK1 (0.39) | AAK1CTSSCTSKNPSR1ALDH1A1 | |
| SCHEMBL18170236 | 0.88 | AAK1 (0.39) | AAK1CTSSCTSKNPSR1MEN1 | |
| SCHEMBL18166854 | 0.88 | AAK1 (0.41) | AAK1CTSSCTSKMEN1KMT2A | |
| SCHEMBL18166875 | 0.86 | AAK1 (0.37) | AAK1CTSSCTSKNPSR1ITGA4 | |
| SCHEMBL28367565 | 0.81 | AAK1 (0.39) | AAK1CTSSCTSKMTNR1AMTNR1B | |
| SCHEMBL29659707 | 0.81 | AAK1 (0.39) | AAK1CTSSCTSKMTNR1AMTNR1B | |
| SCHEMBL18166849 | 0.81 | USP30 (0.36) | AAK1 | |
| SCHEMBL23544353 | 0.79 | SLC7A5 (0.38) | AAK1CTSSCTSKMEN1KMT2A | |
| SCHEMBL31411233 | 0.79 | SLC7A5 (0.38) | AAK1CTSSCTSKMEN1KMT2A | |
| SCHEMBL31411237 | 0.79 | SLC7A5 (0.38) | AAK1CTSSCTSKMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242555-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | NEUBORON MEDTECH LTD. (CN) | 2023-08-03 | — | — | US | disclosed |
| US-11655261-B2 | Method for preparing 18F-BPA and intermediate | NEUBORON MEDTECH LTD. (CN) | 2023-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242555-A1 | METHOD FOR PREPARING 18F-BPA AND INTERMEDIATE | CYP19A1, SHBG, ESR1 | AAK1 2159/4885CTSS 1606/4885CTSK 1792/4885 |
| US-11655261-B2 | Method for preparing 18F-BPA and intermediate | CYP19A1, SHBG, ESR1 | AAK1 2159/4885CTSS 1606/4885CTSK 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.